China Shineway Pharmaceutical Group Limited (C1S) — Defensive Interval Ratio

Latest as of December 2025: 172 days

China Shineway Pharmaceutical Group Limited (C1S) has a Defensive Interval Ratio of 172 days as of December 2025. Defensive assets of €1.18 Billion (cash €-, short-term investments €376.64 Million, receivables €805.93 Million) cover 172 days of daily cash needs of €6.88 Million/day. See C1S current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

172 days
Days of operational coverage

Defensive Assets

€1.18 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€6.88 Million
Current Liabilities ÷ 365

Current Liabilities

€2.51 Billion
EUR

China Shineway Pharmaceutical Group Limited Defensive Interval Ratio (2013–2025)

This chart shows how China Shineway Pharmaceutical Group Limited's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 172 days, meaning defensive assets of €1.18 Billion can fund 172 days of operations without new revenue. See China Shineway Pharmaceutical Group Limi balance sheet quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for China Shineway Pharmaceutical Group Limited (2013–2025)

The table below presents the year-by-year Defensive Interval Ratio for China Shineway Pharmaceutical Group Limited from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of China Shineway Pharmaceutical Group Limi.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 172 days €1.18 Billion €6.88 Million/day €- €376.64 Million ▼ -15 days
2024 187 days €1.26 Billion €6.71 Million/day €- €350.02 Million ▲ +71 days
2023 117 days €778.21 Million €6.67 Million/day €- €20.00 Million ▼ -35 days
2022 152 days €693.61 Million €4.56 Million/day €- €20.23 Million ▲ +11 days
2021 141 days €424.46 Million €3.01 Million/day €- €- ▲ +46 days
2020 95 days €311.79 Million €3.27 Million/day €- €- ▼ -121 days
2019 216 days €697.05 Million €3.23 Million/day €- €- ▼ -44 days
2018 260 days €556.65 Million €2.14 Million/day €- €7.19 Million ▼ -35 days
2017 295 days €573.07 Million €1.94 Million/day €- €16.91 Million ▼ -7 days
2016 302 days €556.06 Million €1.84 Million/day €- €- ▲ +35 days
2015 266 days €511.86 Million €1.92 Million/day €- €- ▲ +22 days
2014 245 days €593.82 Million €2.43 Million/day €- €- ▲ +34 days
2013 210 days €680.05 Million €3.23 Million/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)